February 15, 2022
Thousands of courses of oral COVID-19 treatments sit unused at Mississippi health providers, while the state continues to have a shortage of effective monoclonal antibody treatments. Mississippi State Department of Health officials urge patients to consider these oral medications for preventing severe illness and hospitalization from COVID-19. Photo by Michał Parzuchowski via Unsplash
Stories this photo appears in:
Health Care
MSDH Implores Use of Oral COVID-19 Antiviral Pills amid Monoclonal Antibody Shortage
The Mississippi State Department of Health warned that the state’s allocation of COVID-19 antiviral pills are being under-utilized, while previously relied-upon monoclonal antibody treatments are in short supply.
Comments
Use the comment form below to begin a discussion about this content.
comments powered by Disqus